Ponoi II Management, LLC
data from 30/09/2022
Capitalization
Portfolio size
Portfolio performance
Portfolio performance %
Performance compared to S&P 500 (%)
Stock in Ponoi II Management, LLC
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2022/09/30 | NGM | NGM Biopharmaceuticals Inc | 44.41% | 16.990 M $ | 1298908 | 2020/12/31 | 337.716 K $ | 2.03 % |
| 2022/09/30 | RVMD | Revolution Medicines Inc | 35.31% | 13.508 M $ | 685011 | 2020/12/31 | 157.552 K $ | 1.18 % |
| 2022/09/30 | NRIX | Nurix Therapeutics Inc | 11.14% | 4.262 M $ | 327123 | 2020/12/31 | 117.764 K $ | 2.84 % |
| 2022/09/30 | RAPT | RAPT Therapeutics Inc | 9.14% | 3.498 M $ | 145401 | 2020/12/31 | 844.779 K $ | 31.83 % |